Office Depot Shareholder Alert – National Securities Law Firm Seeks Higher Price For Shareholders In Connection With Acquisition. Encourages Shareholders To Contact Law Firm For More Information
February 4, 2015
New York, New York
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the potential acquisition of Office Depot, Inc. (NASDAQ: “ODP”) (“Office Depot” or the “Company”) on behalf of its shareholders. Staples, Inc. and Office Depot have entered into an agreement for Staples to acquire Office Depot. Office Depot shareholders will receive (i) $7.25 per share in cash and (ii) 0.2188 shares of Staples common stock for each share Office Depot common share outstanding. Based on Staples’s closing stock price on February 2, 2015, the merger consideration is valued at approximately $11 per Office Depot share.
Our investigation seeks to determine whether the offer price of only $11 per share unfairly under-values the true going forward inherent value of the Company and whether shareholders are receiving the maximum value for their shares. Indeed, among other things, the strategic combination of the two companies is expected to deliver at least $1 billion of annualized synergies and the acquisition will be accretive to Staples EPS in the first year post-closing.
If you are a shareholder of Office Depot and would like additional information as to how the acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, please contact us toll free at 1-800-511-7037 or contact us via our website.
Tripp Levy PLLC represents individual and institutional shareholders and, along with its affiliate, has recovered billions of dollars for shareholders in similar actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.” Attorney advertising. Prior results do not indicate a similar outcome.